$Humacyte (HUMA.US)$Humacyte CEO addresses concerns in NYT over FDA approval of Symvess Investing.com -- Dr. Laura Niklason, President and CEO of Humacyte, Inc. (NASDAQ:HUMA), responded to a New York Times (NYSE:NYT) article that questioned the FDA’s approval of Symvess for commercial sales earlier this week. Niklason had previously withheld comment due to the company b...
$Humacyte (HUMA.US)$ Without Elon going over the Financials I expect them to burn through money like it grows on trees and grill up wagyu steaks on your hard earned dollar
3
Report
topcing
OP
:
someone needs to explain assets and liabilities to these Democrats
Humacyte Stock Forum
Investing.com -- Dr. Laura Niklason, President and CEO of Humacyte, Inc. (NASDAQ:HUMA), responded to a New York Times (NYSE:NYT) article that questioned the FDA’s approval of Symvess for commercial sales earlier this week. Niklason had previously withheld comment due to the company b...
No comment yet